Everolimus Tablets 10mg Technical Specification:
| Product Name: | Everolimus Tablets 10mg |
| Brand Name: | Generics |
| Strength: | 0.5mg, 0.25mg, 0.75mg, 5mg, 2.5mg, 7.5mg, 10mg |
| Dosage Form: | Tablets |
| Packing: | 7s, 10s, 28s, 30s, 60s |
| Route of Administration: | For Oral Use only. |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-Cancer |
| Indication: | Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system |
| Storage: | Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F). Store in the original container; protect from light and moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Everolimus Tablets 10mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Everolimus Tablets 10mg
Each uncoated tablet contains:
Everolimus…………………..10 mg
Excipients…………………….q.s.
THERAPEUTIC INDICATIONS:
Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system
CAUTION & WARNING:
CAUTION: It is dangerous to take this preparation except under medical supervision.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
WARNING: To be supplied against demand from Cancer Hospitals, Institutions and against prescription of a Cancer Specialist only.
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.
STORAGE & DOSAGE:
Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F). Store in the original container; protect from light and moisture.
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.
GENERIC NAME OF THE MEDICINAL PRODUCT:
a) Everolimus Tablets 0.5mg
b) Everolimus Tablets 0.25mg
c) Everolimus Tablets 0.75mg
d) Everolimus Tablets 5mg
e) Everolimus Tablets 2.5mg
f) Everolimus Tablets 7.5mg
g) Everolimus Tablets 10mg
b) Everolimus Tablets 0.25mg
c) Everolimus Tablets 0.75mg
d) Everolimus Tablets 5mg
e) Everolimus Tablets 2.5mg
f) Everolimus Tablets 7.5mg
g) Everolimus Tablets 10mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
a) Everolimus Tablets 0.5mg
Each uncoated tablet contains:
Everolimus…………………..0.5 mg
Excipients…………………….q.s.
b) Everolimus Tablets 0.25mg
Each uncoated tablet contains:
Everolimus………………..0.25 mg
Excipients………………….q.s.
c) Everolimus Tablets 0.75mg
Each uncoated tablet contains:
Everolimus…………………0.75 mg
Excipients………………….q.s.
d) Everolimus Tablets 5mg
Each uncoated tablet contains:
Everolimus……………………..5 mg
Excipients……………………….q.s.
e) Everolimus Tablets 2.5mg
Each uncoated tablet contains:
Everolimus…………………..2.5 mg
Excipients……………………q.s.
f) Everolimus Tablets 7.5mg
Each uncoated tablet contains:
Everolimus…………………..7.5 mg
Excipients…………………….q.s.
g) Everolimus Tablets 10 mg
Each uncoated tablet contains:
Everolimus……………………10 mg
Excipients……………………..q.s.
Each uncoated tablet contains:
Everolimus…………………..0.5 mg
Excipients…………………….q.s.
b) Everolimus Tablets 0.25mg
Each uncoated tablet contains:
Everolimus………………..0.25 mg
Excipients………………….q.s.
c) Everolimus Tablets 0.75mg
Each uncoated tablet contains:
Everolimus…………………0.75 mg
Excipients………………….q.s.
d) Everolimus Tablets 5mg
Each uncoated tablet contains:
Everolimus……………………..5 mg
Excipients……………………….q.s.
e) Everolimus Tablets 2.5mg
Each uncoated tablet contains:
Everolimus…………………..2.5 mg
Excipients……………………q.s.
f) Everolimus Tablets 7.5mg
Each uncoated tablet contains:
Everolimus…………………..7.5 mg
Excipients…………………….q.s.
g) Everolimus Tablets 10 mg
Each uncoated tablet contains:
Everolimus……………………10 mg
Excipients……………………..q.s.
THERAPEUTIC INDICATIONS:
Everolimus treats cancer by stopping cancer cells from reproducing and by decreasing blood supply to the cancer cells. Everolimus prevents transplant rejection by decreasing the activity of the immune system
CAUTION & WARNING:
CAUTION: It is dangerous to take this preparation except under medical supervision.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
WARNING: To be supplied against demand from Cancer Hospitals, Institutions and against prescription of a Cancer Specialist only.
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an oncologist/ Cancer Hospital/ Institution only.
WARNING: To be supplied against demand from Cancer Hospitals, Institutions and against prescription of a Cancer Specialist only.
Keep out of reach and sight of children.
Swallow complete tablet, do not crush or chew.
STORAGE & DOSAGE:
Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59 to 86° F). Store in the original container; protect from light and moisture.
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.
Dosage: As directed by Oncologist.
For Oral use. Read the package insert before use.
